Ambalal Sarabhai Enterprises Limited (AMBALALSA.BO)
INR 36.28
(-0.49%)
INR 36.28
(-0.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.13 Billion INR | -1.5% |
| 2022 | 1.14 Billion INR | 3.77% |
| 2021 | 1.1 Billion INR | -18.74% |
| 2020 | 1.36 Billion INR | -3.9% |
| 2019 | 1.41 Billion INR | -22.94% |
| 2018 | 1.83 Billion INR | 5.83% |
| 2017 | 1.73 Billion INR | 25.49% |
| 2016 | 1.38 Billion INR | -3.54% |
| 2015 | 1.43 Billion INR | -19.53% |
| 2014 | 1.78 Billion INR | 5.5% |
| 2013 | 1.69 Billion INR | 13.49% |
| 2012 | 1.48 Billion INR | 0.0% |
| 2009 | 1.62 Billion INR | -9.36% |
| 2008 | 1.79 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -1.37 Billion INR | -221.26% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 1.13 Billion INR | 0.0% |
| 2023 FY | 1.13 Billion INR | -1.5% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.13 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.1 Billion INR | 0.0% |
| 2022 Q4 | 1.14 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 1.14 Billion INR | 3.77% |
| 2021 Q2 | 1.31 Billion INR | 0.0% |
| 2021 Q4 | 1.1 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 1.1 Billion INR | -18.74% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 1.46 Billion INR | 0.0% |
| 2020 Q4 | 1.36 Billion INR | 0.0% |
| 2020 FY | 1.36 Billion INR | -3.9% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q4 | 1.41 Billion INR | 0.0% |
| 2019 FY | 1.41 Billion INR | -22.94% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 1.93 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q4 | 1.83 Billion INR | 0.0% |
| 2018 FY | 1.83 Billion INR | 5.83% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 1.77 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 FY | 1.73 Billion INR | 25.49% |
| 2017 Q4 | 1.73 Billion INR | 0.0% |
| 2017 Q1 | - INR | 0.0% |
| 2016 FY | 1.38 Billion INR | -3.54% |
| 2015 FY | 1.43 Billion INR | -19.53% |
| 2014 FY | 1.78 Billion INR | 5.5% |
| 2013 FY | 1.69 Billion INR | 13.49% |
| 2012 FY | 1.48 Billion INR | 0.0% |
| 2009 FY | 1.62 Billion INR | -9.36% |
| 2008 FY | 1.79 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -4300.21% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 24.636% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -13.504% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -5287.808% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -2008.041% |
| Sunil Healthcare Limited | 902.83 Million INR | -25.262% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -53043.844% |
| MedPlus Health Services Limited | 14.27 Billion INR | 92.077% |
| Zenith Healthcare Limited | 24.03 Million INR | -4605.226% |
| Patidar Buildcon Limited | 25.57 Million INR | -4322.419% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -629.308% |
| Roopa Industries Limited | 493.08 Million INR | -129.351% |
| Smruthi Organics Limited | 485.72 Million INR | -132.83% |
| Trident Lifeline Limited | 331.26 Million INR | -241.392% |
| Bacil Pharma Limited | 1.12 Million INR | -100068.379% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -442.552% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -599.495% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -12.603% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -856.583% |
| PANJON LTD. | 25.38 Million INR | -4355.348% |
| Tyche Industries Limited | 101.64 Million INR | -1012.643% |
| Trimurthi Limited | 101.36 Thousand INR | -1115627.111% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -7449.91% |
| Anuh Pharma Limited | 1.54 Billion INR | 26.785% |
| Crestchem Limited | 23.94 Million INR | -4622.516% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -8336.412% |
| Zenlabs Ethica Limited | 301.35 Million INR | -275.273% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -287.991% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 31.939% |
| Parmax Pharma Limited | 117.56 Million INR | -861.915% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 39.241% |
| Deccan Health Care Limited | 111.33 Million INR | -915.755% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -459.924% |
| Norris Medicines Limited | 278.17 Million INR | -306.546% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 34.027% |
| Veerhealth Care Limited | 62.78 Million INR | -1701.371% |
| Makers Laboratories Limited | 569.18 Million INR | -98.69% |
| Lactose (India) Limited | 536.39 Million INR | -110.833% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -35.739% |
| Mercury Laboratories Limited | 171.18 Million INR | -560.615% |
| Gennex Laboratories Limited | 535.21 Million INR | -111.3% |
| PRAVEG LIMITED | 767.53 Million INR | -47.342% |
| Denis Chem Lab Limited | 289.82 Million INR | -290.205% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 34.107% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -460.985% |
| Colinz Laboratories Limited | 24.1 Million INR | -4591.562% |
| Godavari Drugs Limited | 957.86 Million INR | -18.065% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -378127.759% |
| Zenotech Laboratories Limited | 156.64 Million INR | -621.938% |
| Panchsheel Organics Limited | 340.2 Million INR | -232.42% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -131.567% |
| Vivanza Biosciences Limited | 148.63 Million INR | -660.878% |
| Phaarmasia Limited | 211.49 Million INR | -434.718% |
| Bharat Parenterals Limited | 2.65 Billion INR | 57.429% |
| Medi-Caps Limited | 63.01 Million INR | -1694.625% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -860.629% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -472.977% |
| BDH Industries Limited | 312.53 Million INR | -261.848% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -545.613% |
| Coral Laboratories Limited | 281.83 Million INR | -301.258% |
| Concord Drugs Limited | 249.88 Million INR | -352.567% |
| Beryl Drugs Limited | 85.63 Million INR | -1220.591% |
| Evoq Remedies Limited | 116.23 Million INR | -872.969% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -610.347% |
| Transchem Limited | 6.72 Million INR | -16728.884% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -12646.855% |
| Parnax Lab Limited | 1.17 Billion INR | 3.401% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -2594.418% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -6.926% |
| Cian Healthcare Limited | 1.03 Billion INR | -9.334% |
| Trinity League India Limited | 876 Thousand INR | -128998.288% |
| Syschem (India) Limited | 1.07 Billion INR | -5.621% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 44.646% |
| Natural Capsules Limited | 1.47 Billion INR | 23.443% |
| Auro Laboratories Limited | 433.09 Million INR | -161.12% |